Zenyaku Kogyo appeared to be the Corporate Investor, which was created in 1950. The venture was found in Asia in Japan. The main department of described Corporate Investor is located in the Tokyo.
Among the most successful fund investment fields, there are Medical, Health Care. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Theraclone Sciences. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 5 - 10 millions dollars. The important activity for fund was in 2013.
The standard case for the fund is to invest in rounds with 6 partakers. Despite the Zenyaku Kogyo, startups are often financed by MPM Capital, HealthCare Ventures, Canaan Partners. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, ReproCELL, Nissei Capital. In the next rounds fund is usually obtained by Tohoku University Venture Partners, Silicon Valley Bank, ReproCELL.
Related Funds
Fund Name | Location |
Aderans | Japan, Tokyo |
Ag Innovation Development Group | - |
Blackstone Life Sciences | Cambridge, Massachusetts, United States |
Broadband Capital Investments | Florida, Miami, United States |
Celanese | Irving, Texas, United States |
Foundation Venture Capital Group | New Brunswick, New Jersey, United States |
GITPx | Central, Central Region, Singapore |
Investion | Amsterdam, Noord-Holland, The Netherlands |
Jennison Associates | New York, New York, United States |
Joho Capital | New York, New York, United States |
Leede Jones Gable | Alberta, Calgary, Canada |
Ramot | Israel, Tel Aviv, Tel Aviv District |
RBC | Canada, Ontario, Toronto |
Rudin Ventures | - |
Seneca Creek Ventures | Boston, Massachusetts, United States |
The JumpFund | Chattanooga, Tennessee, United States |
TS Investment | Dubai, United Arab Emirates |
Valquest Partners | Beirut, Beyrouth, Lebanon |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Theraclone Sciences | $8M | 25 Mar 2013 | Seattle, Washington, United States | ||
Theraclone Sciences | $10M | 08 Sep 2011 | Seattle, Washington, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Theraclone Sciences | $8M | 25 Mar 2013 | Seattle, Washington, United States | ||
Theraclone Sciences | $10M | 08 Sep 2011 | Seattle, Washington, United States |